Le Lézard
Classified in: Health
Subject: CCA

Boston Scientific Announces Transcatheter Cardiovascular Therapeutics 2020 Investor Update and Conference Call Discussing Third Quarter 2020 Results


MARLBOROUGH, Mass., Oct. 1, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast an investor update at the virtual 2020 Transcatheter Cardiovascular Therapeutics (TCT) on Thursday, October 15 from 1:00 ? 2:00 p.m. EDT. Joe Fitzgerald, executive vice president and president, Interventional Cardiology; Michael Jaff, D.O., vice president and chief medical officer, clinical affairs, technology and innovation, Peripheral Interventions; Dr. Ian Meredith, AM, executive vice president and global chief medical officer; and Jeff Mirviss, executive vice president and president, Peripheral Interventions will provide a business update and answer questions from investors about the Boston Scientific cardiovascular portfolio.

On Wednesday, October 28, 2020 Boston Scientific will webcast its conference call discussing financial results and business highlights for the third quarter ended September 30, 2020. The call will begin at 8:00 a.m. EDT, hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the third quarter on October 28 prior to the conference call.

A live webcast and replay of the webcast for each event will be accessible at investors.bostonscientific.com. The replay will be available beginning approximately one hour following the completion of each event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS


Media:

Investors:

Kate Haranis

Susie Lisa, CFA

508-683-6585 (office)

508-683-5565 (office)

Media Relations

Investor Relations

Boston Scientific Corporation

Boston Scientific Corporation

[email protected]

[email protected]

 

SOURCE Boston Scientific Corporation


These press releases may also interest you

at 16:10
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update
Arcus Biosciences , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will host a conference call and webcast on...

at 16:05
Biote Schedules First Quarter 2024 Financial Results Release and Conference Call
biote Corp. ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide first quarter financial...

at 16:02
FDA Roundup: April 23, 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a new initiative aimed to help reimagine the home environment as an integral part of the health care system....

at 15:52
Getlabs and Instalab Announce Nationwide Partnership to Bring Prevention-Based Medicine to Everyone
Getlabs, the nationwide leader for at-home diagnostics, is excited to announce a strategic partnership with Instalab, a pioneering proactive healthcare company. Through Getlabs' widespread presence throughout the United States, Instalab can provide...

at 15:45
Core Sound Imaging Named 2024 SIIA CODiE Award Finalist in Most Innovative Tech Company
Core Sound Imaging, creator of the Studycast system, today announces that Core Sound Imaging was named a 2024 SIIA CODiE Award Finalist in the Most Innovative Tech Company category. CODiE Finalists represent the best products, services and people in...

at 15:43
American Foundation for Suicide Prevention Statement on the Release of the 2024 National Strategy for Suicide Prevention
Today marks the release of the 2024 National Strategy for Suicide Prevention, an important milestone and rallying point for organizations nationwide working to address this important public health issue. The American Foundation for Suicide Prevention...

More news about Health...


News published on and distributed by: